Detalhe da pesquisa
1.
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Int J Cancer
; 154(6): 1043-1056, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994647
2.
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment.
J Hepatol
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570034
3.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972660
4.
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study.
Liver Int
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38618972
5.
Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
Oncology
; 101(5): 283-291, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657420
6.
Experience and perspectives of end-of-life care discussion and physician orders for life-sustaining treatment of Korea (POLST-K): a cross-sectional study.
BMC Med Ethics
; 24(1): 18, 2023 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882795
7.
Perceptions of the meaning of life among Korean patients with advanced cancer: A mixed-methods study.
Palliat Support Care
; 21(4): 658-669, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36017653
8.
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma.
Liver Int
; 42(3): 674-681, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34792284
9.
Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab.
Gastric Cancer
; 25(4): 794-803, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524883
10.
Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenib.
Future Oncol
; 18(27): 3021-3030, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35903991
11.
Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer.
Support Care Cancer
; 30(9): 7431-7438, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35622149
12.
"Teachable Moment": Effects of an Educational Program on Knowledge and Quality of Life of Korean Breast Cancer Survivors.
J Cancer Educ
; 37(3): 812-818, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025451
13.
Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study.
Lancet Oncol
; 22(11): 1560-1572, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34656226
14.
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic breast cancer.
Int J Cancer
; 2021 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33905134
15.
Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation.
Support Care Cancer
; 29(2): 975-986, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556712
16.
Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea.
Support Care Cancer
; 29(9): 5383-5390, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33683460
17.
Unmet needs related to the quality of life of advanced cancer patients in Korea: a qualitative study.
BMC Palliat Care
; 20(1): 58, 2021 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849508
18.
Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act.
BMC Palliat Care
; 20(1): 63, 2021 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33906659
19.
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
BMC Cancer
; 20(1): 1193, 2020 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33276759
20.
CD45dimCD34+CD38-CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia.
BMC Cancer
; 20(1): 285, 2020 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32252668